TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2023-09-19
倪衍玄NI, YEN-HSUAN
- 計畫主持人
- 執行臨床試驗年資 17 年 9 個月
發表文獻
31筆
11
Chen JY, Wu JF, Kimura A, Nittono H, Liou BY, Lee CS, Chen HS, Chiu YC, Ni YH, Peng SS, Lee WT, Tsai IJ, Chang MH, Chen HL. AKR1D1 and CYP7B1 mutations in patients with inborn errors of bile acid metabolism: Possibly underdiagnosed diseases. Pediatr Neonatol. 2020 Feb;61(1):75-83. doi: 10.1016/j.pedneo.2019.06.009. Epub 2019 Jul 4. PMID: 31337596.
12
Wen WH, Chen HL, Shih TT, Wu JF, Ni YH, Lee CN, Zhao LL, Lai MW, Mu SC, Tung YC, Hsu HY, Chang MH; Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study)(‡). Long-term growth and bone development in children of HBV-infected mothers with and without fetal exposure to tenofovir disoproxil fumarate. J Hepatol. 2020 Jun;72(6):1082-1087. doi: 10.1016/j.jhep.2020.01.021. Epub 2020 Feb 8. PMID: 32044401.
13
Huang CY, Chang MH, Chen HL, Ni YH, Hsu HY, Wu JF. Bilirubin level 1 week after hepatoportoenterostomy predicts native liver survival in biliary atresia. Pediatr Res. 2020 Mar;87(4):730-734. doi: 10.1038/s41390-019-0610-6. Epub 2019 Oct 16. PMID: 31618755.
14
Chen HS, Wu JF, Chen HL, Ni YH. Does one-man method better than two-man method for colonoscopy insertion in children. J Formos Med Assoc. 2019 Nov;118(11):1546-1550. doi: 10.1016/j.jfma.2018.12.024. Epub 2019 Jan 9. PMID: 30638735.
15
Hsu CT, Chang MH, Ho MC, Chang HH, Lu MY, Jou ST, Ni YH, Chen HL, Hsu HY, Wu JF. Post-transplantation lymphoproliferative disease in pediatric liver recipients in Taiwan. J Formos Med Assoc. 2019 Nov;118(11):1537-1545. doi: 10.1016/j.jfma.2018.12.023. Epub 2019 Jan 8. PMID: 30630698.
16
Chien MM, Chang MH, Chang KC, Lu FT, Chiu YC, Chen HL, Ni YH, Hsu HY, Wu JF. Prognostic parameters of pediatric acute liver failure and the role of plasma exchange. Pediatr Neonatol. 2019 Aug;60(4):389-395. doi: 10.1016/j.pedneo.2018.09.006. Epub 2018 Sep 24. PMID: 30361144.
17
Chien RN, Kao JH, Peng CY, Chen CH, Liu CJ, Huang YH, Hu TH, Yang HI, Lu SN, Ni YH, Chuang WL, Lee CM, Wu JC, Chen PJ, Liaw YF. Taiwan consensus statement on the management of chronic hepatitis B. J Formos Med Assoc. 2019 Jan;118(1 Pt 1):7-38. doi: 10.1016/j.jfma.2018.11.008. Epub 2018 Dec 6. PMID: 30527436.
18
Chen HS, Ho MC, Hu RH, Wu JF, Chen HL, Ni YH, Hsu HY, Jeng YM, Chang MH. Roles of Epstein-Barr virus viral load monitoring in the prediction of posttransplant lymphoproliferative disorder in pediatric liver transplantation. J Formos Med Assoc. 2019 Sep;118(9):1362-1368. doi: 10.1016/j.jfma.2018.12.007. Epub 2019 Jan 3. PMID: 30612881.
19
Chen HL, Ni YH, Chen PJ, Chang MH. Antiviral treatment for hepatitis B in infancy: Still an issue for debate. J Hepatol. 2019 Dec;71(6):1264-1265. doi: 10.1016/j.jhep.2019.07.023. Epub 2019 Sep 30. PMID: 31582267.
20
Yang YJ, Ni YH. Gut microbiota and pediatric obesity/non-alcoholic fatty liver disease. J Formos Med Assoc. 2019 Mar;118 Suppl 1:S55-S61. doi: 10.1016/j.jfma.2018.11.006. Epub 2018 Dec 1. PMID: 30509561.
